Chitrang J. Trivedi

Ahmedabad, GJ, India

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Peptide-Based Anti-PCSK9 Product for Long-Lasting Management of Hypercholesterolemia.

Peptide-Based Anti-PCSK9 Product for Long-Lasting Management of Hypercholesterolemia.

Journal: Vaccines

Published: July 02, 2025

Discovery of ZYDG2: A potent, selective, and safe GPR40 agonist for treatment of type 2 diabetes.

Discovery of ZYDG2: A potent, selective, and safe GPR40 agonist for treatment of type 2 diabetes.

Journal: The Journal of pharmacology and experimental therapeutics

Published: October 29, 2024

Saroglitazar suppresses the hepatocellular carcinoma induced by intraperitoneal injection of diethylnitrosamine in C57BL/6 mice fed on choline deficient, l-amino acid- defined, high-fat diet.

Saroglitazar suppresses the hepatocellular carcinoma induced by intraperitoneal injection of diethylnitrosamine in C57BL/6 mice fed on choline deficient, l-amino acid- defined, high-fat diet.

Journal: BMC cancer

Published: July 05, 2022

Dual PPARα/γ agonist saroglitazar improves liver histopathology and biochemistry in experimental NASH models.

Dual PPARα/γ agonist saroglitazar improves liver histopathology and biochemistry in experimental NASH models.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: February 21, 2017

Hypothalamic leptin action is mediated by histone deacetylase 5.

Hypothalamic leptin action is mediated by histone deacetylase 5.

Journal: Nature communications

Published: November 24, 2015

Tachykinin-1 in the central nervous system regulates adiposity in rodents.

Tachykinin-1 in the central nervous system regulates adiposity in rodents.

Journal: Endocrinology

Published: March 10, 2015

Saroglitazar, a novel PPARα/γ agonist with predominant PPARα activity, shows lipid-lowering and insulin-sensitizing effects in preclinical models.

Saroglitazar, a novel PPARα/γ agonist with predominant PPARα activity, shows lipid-lowering and insulin-sensitizing effects in preclinical models.

Journal: Pharmacology research & perspectives

Published: January 28, 2015

High-density lipoprotein maintains skeletal muscle function by modulating cellular respiration in mice.

High-density lipoprotein maintains skeletal muscle function by modulating cellular respiration in mice.

Journal: Circulation

Published: October 31, 2013

The orphan receptor Gpr83 regulates systemic energy metabolism via ghrelin-dependent and ghrelin-independent mechanisms.

The orphan receptor Gpr83 regulates systemic energy metabolism via ghrelin-dependent and ghrelin-independent mechanisms.

Journal: Nature communications

Published: October 30, 2012

Exercise protects against high-fat diet-induced hypothalamic inflammation.

Exercise protects against high-fat diet-induced hypothalamic inflammation.

Journal: Physiology & behavior

Published: January 03, 2012

Showing 1-10 of 10

Last Updated: 09/26/2026